DK57492D0 - Farmaceutiske praeparater af n-phenylbenzamidderivater - Google Patents

Farmaceutiske praeparater af n-phenylbenzamidderivater

Info

Publication number
DK57492D0
DK57492D0 DK92574A DK57492A DK57492D0 DK 57492 D0 DK57492 D0 DK 57492D0 DK 92574 A DK92574 A DK 92574A DK 57492 A DK57492 A DK 57492A DK 57492 D0 DK57492 D0 DK 57492D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
benzamide derivatives
phenyl benzamide
phenyl
derivatives
Prior art date
Application number
DK92574A
Other languages
English (en)
Other versions
DK168268B1 (da
DK57492A (da
Inventor
Gerhard Satzinger
Manfred Herrmann
Edgar Fritschi
Ute Weiershausen
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of DK57492D0 publication Critical patent/DK57492D0/da
Publication of DK57492A publication Critical patent/DK57492A/da
Application granted granted Critical
Publication of DK168268B1 publication Critical patent/DK168268B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK057492A 1983-02-19 1992-05-01 Farmaceutiske præparater af N-phenylbenzamidderivater DK168268B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3305755 1983-02-19
DE19833305755 DE3305755A1 (de) 1983-02-19 1983-02-19 N-phenyl-benzamid-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkranungen des immunsystems

Publications (3)

Publication Number Publication Date
DK57492D0 true DK57492D0 (da) 1992-05-01
DK57492A DK57492A (da) 1992-05-01
DK168268B1 DK168268B1 (da) 1994-03-07

Family

ID=6191259

Family Applications (2)

Application Number Title Priority Date Filing Date
DK076784A DK166383C (da) 1983-02-19 1984-02-17 N-phenyl-benzamidderivater, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse
DK057492A DK168268B1 (da) 1983-02-19 1992-05-01 Farmaceutiske præparater af N-phenylbenzamidderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK076784A DK166383C (da) 1983-02-19 1984-02-17 N-phenyl-benzamidderivater, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse

Country Status (16)

Country Link
US (3) US4857662A (da)
EP (1) EP0116967B1 (da)
JP (1) JPS59163356A (da)
AT (1) ATE17715T1 (da)
AU (1) AU565185B2 (da)
CA (1) CA1244050A (da)
DD (1) DD216452A5 (da)
DE (2) DE3305755A1 (da)
DK (2) DK166383C (da)
ES (1) ES529811A0 (da)
GR (1) GR79506B (da)
HU (1) HU195474B (da)
IE (1) IE56587B1 (da)
SU (1) SU1333234A3 (da)
YU (1) YU43563B (da)
ZA (1) ZA841187B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
EP0194529B1 (de) * 1985-03-01 1992-09-02 Gödecke Aktiengesellschaft Verwendung von 2-(Aminophenyl)-benzimidazol-Derivaten für die Herstellung von Arzneimitteln zur Bekämpfung maligner und nicht maligner proliferativer sowie autoimmuner Erkrankungen und zur Immunsuppression bei Transplantationen
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
DE3625359A1 (de) * 1986-07-26 1988-02-04 Goedecke Ag N-(2'-aminophenyl)-benzamid-derivat, verfahren zu dessen herstellung und dessen verwendung bei der bekaempfung neoplastischer erkrankungen
DE3705117A1 (de) * 1987-02-18 1988-09-01 Goedecke Ag Verwendung von benzothiazepin-derivaten, insbesondere diltiazem bei der protektion von lymphozyten
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US6274635B1 (en) 1999-03-22 2001-08-14 Immugen Pharmaceuticals Inc. Alkylated resorcinol derivatives for the treatment of immune diseases
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
US7102009B2 (en) 2001-01-12 2006-09-05 Amgen Inc. Substituted amine derivatives and methods of use
US6995162B2 (en) 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
US20030134836A1 (en) * 2001-01-12 2003-07-17 Amgen Inc. Substituted arylamine derivatives and methods of use
US6878714B2 (en) * 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
US20030186942A1 (en) * 2002-01-16 2003-10-02 Crooks Peter A. Compounds of use in the treatment of epilepsy, seizure, and electroconvulsive disorders
GB0202873D0 (en) 2002-02-07 2002-03-27 Novartis Ag Organic compounds
AU2003214226A1 (en) * 2002-03-18 2003-10-08 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
US7307088B2 (en) * 2002-07-09 2007-12-11 Amgen Inc. Substituted anthranilic amide derivatives and methods of use
WO2006063109A2 (en) * 2004-12-09 2006-06-15 Insys Therapeutics, Inc. Room-temperature stable dronabinol formulations
US8247556B2 (en) * 2005-10-21 2012-08-21 Amgen Inc. Method for preparing 6-substituted-7-aza-indoles
BRPI0715328A2 (pt) * 2006-08-04 2013-07-09 Insys Therapeutics Inc formulaÇço, e, dispositivo de dose unitÁria ou de dose méltipla para a administraÇço sublingual de uma droga
WO2009020666A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
WO2009076234A2 (en) * 2007-12-07 2009-06-18 University Of Maryland, Baltimore Synthesis methods of histone deacetylase inhibitors (hdacis)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2022579A (en) * 1929-02-14 1935-11-26 Turski Joseph Felix 2,3-hydroxy-naphthoic acid arylamide
GB1123457A (en) * 1966-07-11 1968-08-14 Warner Lambert Pharmaceutical 2-amino-4'-(diethylamino)-2'-methyl benzanilide and preparation thereof
US3488388A (en) * 1967-03-29 1970-01-06 Universal Oil Prod Co N-substituted aminobenzenecarboxamides
US3926922A (en) * 1974-03-14 1975-12-16 Polaroid Corp Polyurethane elastomers prepared from diamine curing agents
FR2279822A1 (fr) * 1974-07-24 1976-02-20 Ugine Kuhlmann Nouveaux colorants disazoiques hydrosolubles et nouvelles matieres premieres utilisables pour leur preparation
JPS5671075A (en) * 1979-11-12 1981-06-13 Sumitomo Chem Co Ltd Novel imidazole derivative
JPS5721320A (en) * 1980-07-11 1982-02-04 Chugai Pharmaceut Co Ltd Blood sugar level depressing agent

Also Published As

Publication number Publication date
US4857662A (en) 1989-08-15
ES8501368A1 (es) 1984-11-16
EP0116967A1 (de) 1984-08-29
DD216452A5 (de) 1984-12-12
DK76784D0 (da) 1984-02-17
YU28784A (en) 1986-08-31
GR79506B (da) 1984-10-30
DK166383B (da) 1993-05-10
JPH041738B2 (da) 1992-01-14
ZA841187B (en) 1984-09-26
SU1333234A3 (ru) 1987-08-23
AU2440184A (en) 1984-08-23
DE3305755C2 (da) 1989-08-03
YU43563B (en) 1989-08-31
US4816485A (en) 1989-03-28
EP0116967B1 (de) 1986-01-29
US4933368A (en) 1990-06-12
DE3305755A1 (de) 1984-08-23
CA1244050A (en) 1988-11-01
AU565185B2 (en) 1987-09-10
ES529811A0 (es) 1984-11-16
IE840122L (en) 1984-08-19
DK168268B1 (da) 1994-03-07
ATE17715T1 (de) 1986-02-15
DK57492A (da) 1992-05-01
IE56587B1 (en) 1991-10-09
DK166383C (da) 1993-09-27
DK76784A (da) 1984-08-20
JPS59163356A (ja) 1984-09-14
DE3460026D1 (en) 1986-03-13
HU195474B (en) 1988-05-30

Similar Documents

Publication Publication Date Title
DK57492D0 (da) Farmaceutiske praeparater af n-phenylbenzamidderivater
DK0396083T3 (da) Heterocykliske N-oxidderivater af substituerede benzo(5,6)-cycloheptapyridiner, præparater og anvendelsesfremgangsmåder
CY1107509T1 (el) Αμινοθειαζολες ως αναστολεις κυκλινη - εξαρτωμενων κινασεων
DE69618231D1 (de) TETRAHYDROIMIDAZOPYRIDOINDOLDIONE ALS cGMP SPEZIFISCHE PDE HEMMER
FR2631625B1 (fr) Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique
DK157489C (da) N-substituerede pyridiniumforbindelser og farmaceutiske praeparater indeholdende disse
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
FR2552083B1 (fr) Derives de (alkynyloxy-3 hydroxy-2-propyl)-4 piperazinyl-1 n-phenyl acetamide, leur preparation et leur application en therapeutique
DK0607129T3 (da) Methylpiperazinoazepinderivater, deres fremstilling og deres anvendelse
DE3366181D1 (en) 2-aminomethyl-6-sulfamoylphenol derivatives, process for their preparation, their use and pharmaceutical preparations based on these compounds
NO811185L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tiazolderivater.
DE3862660D1 (de) 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel.
DK163922C (da) 2,3-dihydro-3-phenyl-2-benzofuranonderivater, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem
NO172120C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler
FI882388A (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
ES2115303T3 (es) Uso de compuestos de 5-tia-1,4-diazabiciclo(4.2.0)octan-3,8-dioxo en terapia antitumoral.
FI841293A0 (fi) Iminosulfonamider och foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska prepara preparat samt deras anvaendning.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired